Kerstin de Wit, MBChB, MSc, MD, MRCP, FRCEM, FRCPC

Associate Professor
Department of Emergency Medicine, Queen’s University

Kerstin de Wit, Associate Professor, Queen's University and McMaster University, MBChB, MSc, MD, MRCP, FRCEM, FRCPC.

Kerstin de Wit trained in internal medicine, emergency medicine and research in the UK. She completed a Thrombosis Fellowship in Ottawa in 2013. Since then, she has worked in both emergency medicine and thrombosis. She leads a research program which focuses on the diagnosis of bleeding and clotting disorders in the emergency department, funded by CIHR.

Presentation(s):

• OC 31.3 - Canadian prospective external validation of YEARS and age-adjusted pulmonary embolism testing

  Monday, July 11, 2022
  11:15 AM – 11:30 AM

• OC 31.5 - Identifying which emergency department patients should be tested for pulmonary embolism

  Monday, July 11, 2022
  11:45 AM – 12:00 PM

• SSC 14.05 - Standards for Diagnosis in Pulmonary Embolism and Deep Vein Thrombosis in Cancer Patients

  Monday, July 11, 2022
  5:07 PM – 5:18 PM

• PB0676 - Risk factors for bleeding in people living with Hemophilia A and B treated with regular prophylaxis: a systematic review of the literature.

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• SOA 16.2 - Risk Stratification for Acute VTE

  Tuesday, July 12, 2022
  8:20 AM – 8:40 AM

• OC 60.6 - Clinical Pathways for VTE Diagnosis

  Tuesday, July 12, 2022
  2:45 PM – 4:00 PM

• PB1324 - Evaluating routine data sources and efficient methods to determine the incidence of venous thromboembolism and major bleeding in unselected medical and surgical inpatients.

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1360 - Inter-rater reliability of the UK Department of Health VTE risk assessment tool for medical and surgical hospital admissions

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1361 - Comparing the proportion of medical and surgical hospital inpatients requiring pharmacological thromboprophylaxis using different risk assessment models: an observational cohort study

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1362 - Decision-analysis modelling of effectiveness and cost-effectiveness of thromboprophylaxis for medical inpatients

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM